Skip to main content

Table 3 Baseline cardiovascular magnetic resonance parameters

From: Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study

 Healthy controlsCirrhosisChild-Pugh
class A/B
Child-Pugh
class C
P valueP value*
N = 20N = 33N = 10N = 23
LVEF (%)63.4 ± 6.467.8 ± 6.966.1 ± 6.568.5 ± 7.10.0270.368
LV EDV (mL)135 ± 20150 ± 47153 ± 42149 ± 500.1010.811
LV ESV (mL)51 ± 1649 ± 2152 ± 1848 ± 230.7520.604
Stroke volume (mL)85 ± 15100 ± 29101 ± 2899 ± 300.0250.845
Cardiac index (L/min)3.3 ± 0.74.3 ± 1.13.8 ± 1.04.5 ± 1.10.0020.073
LV mass index (g/m2)76.8 ± 13.070.7 ± 15.870.1 ± 13.071.0 ± 17.10.1380.858
LV mass/LV-EDV ratio0.9 ± 0.20.8 ± 0.30.8 ± 0.30.9 ± 0.20.1260.875
Presence of LGE0 (0%)1 (3.0%)0 (0%)1 (4.3%)0.4320.503
Native T1 (msec)1174 ± 651228 ± 791216 ± 601233 ± 870.0010.584
ECV (%)25.4 ± 1.931.6 ± 5.127.2 ± 3.433.6 ± 4.4< 0.0010.001
  1. LVEF left ventricular ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, LGE late gadolinium enhancement, ECV extracellular volume fraction
  2. P value between normal and all LC groups
  3. *P value between Child-Pugh class A/B and Child-Pugh class C